Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

Expert panel - A/Prof Samantha Hocking, Prof John Dixon, facilitated by A/Prof Ralph Audehm

GLP-1 Prescribing Expert Panel Discussion

Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

Arrhythmia Management in Primary Care

Dr Rupert Hinds

Dr Rupert Hinds

Infant Allergy Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 29 October 2024